Abstract
Rationale
Repeated withdrawals from chronic forced ethanol exposure sensitize animals to withdrawal-induced deficits in social interaction behavior. The deficits in social interaction behavior following withdrawal from continuous ethanol exposure can be reduced following acute treatments with 5-HT2C antagonists or 5-HT1A agonists.
Objectives
The present study investigated whether prior treatment with these serotonergic agents during early withdrawals in rats subjected to repeated withdrawals from ethanol exposure would ameliorate the social interaction deficits observed following the final withdrawal.
Methods
Sprague-Dawley rats were exposed to three cycles of 5 days forced ethanol (7%, w/v), with 2 days of control diet after the first and second cycles. Drugs were administered IP 4 h after removal of ethanol on the first and second cycles but not the third in one group and 4.5 h after removal of ethanol on the third cycle in another. The social interaction test was performed 5 h after removal of ethanol on the third cycle. Drugs tested included SB-242084, a 5-HT2C antagonist; buspirone, a 5-HT1A partial agonist; WAY-100635, a 5-HT1A antagonist; ketanserin, a 5-HT2A antagonist; ritanserin, a mixed 5-HT2A/2C antagonist; and Ro-601075, a 5-HT2C agonist.
Results
Both SB-242084 and buspirone reduced ethanol withdrawal-induced deficits in social interaction when given either acutely 30 min before the test or at 4 h after withdrawal from the first and second cycles. WAY-100635 and ketanserin were completely ineffective regardless of mode of treatment. In contrast, the 5-HT2C agonist, Ro-601075, accentuated the withdrawal-induced deficit in social interaction behavior in rats exposed to either 4.5 or 7% ethanol diet.
Conclusions
These results support the utility of 5-HT1A agonists and 5-HT2C antagonists in reducing anxiety-like behavior induced by ethanol withdrawal and reducing the adaptive changes associated with repeated withdrawals.
Similar content being viewed by others
References
Amano M, Goto A, Sakai A, Achita M, Takahashi N, Hara C, Ogawa N (1993) Comparison of the anticonflict effect of buspirone and its major metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in rats. Jpn J Pharmacol 61:311–317
Andrews N, File SE (1993) Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supported neurochemical and behavioural evidence. Psychopharmacology 112: 21–25
Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S (2001) Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 4:399–408
Ballenger JC, Post RM (1978) Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry 133:1–14
Berggren U, Eriksson M, Fahlke C, Balldin J (2002) Is long-term heavy alcohol consumption toxic for brain serotonergic neurons? Relationship between years of excessive alcohol consumption and serotonergic neurotransmission. Drug Alcohol Depend 65:159–165
Boess FG, Martin H (1994) Molecular biology of 5-HT receptors Neuropharmacology 33:275–317
Bonhaus DW, Weinhardt KK, Taylor M, De Souza A, McNeeley PM, Szezcpanski K, Fontana DJ, Trinh J, Rocha CL, Dawson MW, Flippin LA, Eglin RM (1997) RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology 36:621–629
Bristow LJ, O'Connor D, Watts R, Duxon MS, Hutson PH (2000) Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY-100635, in the rat. Neuropharmacology 39:123–132
Bruno F (1989) Buspirone in the treatment of alcoholic patients. Psychopathology 22:49–59
Cao BJ, Rodgers RJ (1997) Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze. Neuropharmacology 36:1089–1097
Curran GM Flynn HA, Kirchner J, Booth BM (2000) Depression after alcohol treatment as a risks factor for relapse among male veterans. J Subst Abuse Treat 19:259–265
De Soto CB, O'Donnell WE, De Soto JL (1989) Long-term recovery in alcoholics. Alcohol Clin Exp Res 13:693–697
Dougherty RJ, Gates RR (1990) The role of buspirone in the management of alcohol withdrawal: a preliminary investigation. J Subst Abuse Treat 7:189–192
Driessen M, Meier S. Hill A (2001) The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol 36:249–255
Fawcett J, Kravitz HM, McGuire M, Easton M, Ross J, Pisani V, Fogg LF, Clark D, Whitney M, Kravitz G, Javaid J, Teas G (1999) Pharmacological treatments for alcoholism: revisiting lithium and considering buspirone. Alcohol Clin Exp Res 24:666–674
File SE (1980) The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Meth 2:219–238
File SE, Andrews N, al-Farhan M, Wu PY (1993) The role of 5-HT in the anxiogenic effects of acute ethanol withdrawal and in the long-lasting cognitive deficits. Alcohol Alcohol 28:495–499
Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A (1995) A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur J Pharmacol 281:81–88
Frye GD, McCown TJ, Breese GR (1983) Differential sensitivity of ethanol withdrawal signs in the rat to γ-aminobutyric acid (GABA) mimetics: blockade of audiogenic seizures but not forelimb tremors. J Pharmacol Exp Ther 226:720–725
George DT, Rawlings R, Eckhardt MJ, Phillips MJ, Shoaf SE, Linnoila M (1999) Buspirone treatment of alcoholism: age of onset, and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking. Alcohol Clin Exp Res 23:272–278
Gonzalez LE, File SE, Overstreet DH (1998) Selectively bred lines of rat differ in social interaction and hippocampal 5-HT1A receptor function: a link between anxiety and depression? Pharmacol Biochem Behav 59:787–792
Hedlund L, Wahlstrom G (1999) Acute and long-term effects of buspirone treatment on voluntary ethanol intake in a rat model of alcoholism. Alcohol Clin Exp Res 23:822–827
Kampov-Polevoy AB, Matthews DB, Gause L, Morrow AL, Overstreet DH (2000) P rats develop physical dependence on alcohol via voluntary drinking: changes in seizure thresholds, anxiety, and patterns of alcohol drinking. Alcohol Clin Exp Res 24:278–284
Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP (1997) SB-242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36:609–620
Kennett G, Lightowler S, Trail B, Bright F, Bromidge S (2000) Effects of Ro-600175, a 5-HT2C receptor agonist, in three animal models of anxiety. Eur J Pharmacol 387:197–204
Knapp DJ, Duncan GE, Crews FT, Breese GR (1998) Induction of Fos-like proteins and ultrasonic vocalizations during ethanol withdrawal: further evidence for withdrawal-induced anxiety. Alcohol Clin Exp Res 22:481–493
Knapp DJ, Overstreet DH, Breese GR (2000) Pharmacological modulation of anxiety in rats during alcohol withdrawal. Presented at 23rd Annual Meeting of the Research Society on Alcoholism, Denver, CO, June 24–29, 2000. Alcohol Clin Exp Res 24:90A
Knapp DJ, Overstreet DH, Breese GR (2001) Persistent effects of repeated ethanol withdrawal are blunted by pharmacological treatments during early withdrawal episodes. Presented at 24th Annual Meeting of Research Society on Alcoholism, Montreal, Canada, June 23–28, 2001. Alcohol Clin Exp Res 25:23A
Kranzler H, Meyer RF (1992) An open trial of buspirone in alcoholics. J Clin Psychopharmacol 9:379–380
Lal H, Prather PL, Rezazadeh SM (1991) Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: reversal by buspirone. Alcohol 8:467–471
Lal H, Prather PL, Rezazadeh SM (1993) Potential role of 5-HT1C and 5-HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal. Alcohol Clin Exp Res 17:411–417
Malcolm R, Anton RF, Randall CL, Johnston A, Brady K, Thevos A (1992) A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res 16:1007–1013
Malec TS, Malec EA, Dongier M (1996) Efficacy of buspirone in alcohol dependence: a review. Alcohol Clin Exp Res 20:853–858
McCown TJ, Breese GR (1990) Multiple withdrawals from ethanol "kindles" inferior collicular seizure activity: evidence for kindling of seizures associated with alcoholism. Alcohol Clin Exp Res 14:394–399
Meert TF (1994) Ritanserin and alcohol abuse and dependence. Alcohol Alcohol 2:523–530
Miller WR, Harris RJ (2000) A simple scale of Gorski's warning signs for relapse. J Stud Alcohol 61:759–765
Moy SS, Knapp DJ, Criswell HE, Breese GR (1997) Flumazenil blockade of anxiety following ethanol withdrawal in rats. Psychopharmacology 131:354–360
Moy SS, Knapp DJ, Duncan GE, Breese GR (2000) Enhanced ultrasonic vocalization and Fos protein expression following ethanol withdrawal: effects of flumazenil. Psychopharmacology 152:208–215
Naranjo CA, Poulos CX, Lanctot KL, Bremner KER, Kowk M, Umana M (1995) Ritanserin, a central 5-HT2 antagonist, in heavy social drinkers: desire to drink, alcohol intake and related effects. Addiction 90:893–905
Overstreet DH, Rezvani AH, Pucilowski O, Janowsky DS (1994) 5-HT receptors: implications for the neuropharmacology of alcohol and alcoholism. Alcohol Alcohol Suppl 2:207–212
Overstreet DH, Knapp DJ, Breese GR (2002) Accentuated decrease in social interaction in rats repeatedly withdrawn from ethanol. Alcohol Clin Exp Res 26:1259–1268
Pandey SC, Pandey GN (1996) Modulation of serotonin2A/2C receptors and these receptor-linked phosphoinositide system by ethanol. Behav Brain Res 73:235–238
Pandey SC, Piano MR, Schwertz DW, Davis JM, Pandey GN (1992) Effect of ethanol administration and withdrawal on serotonin receptor subtypes and receptor-mediated phosphoinositide hydrolysis in rat brain. Alcohol Clin Exp Res 16:1110–1116
Soloff PH, Lynch KG, Moss HB (2000) Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study. Alcohol Clin Exp Res 24:1609–1619
Stahl S (1997) Mixed depression and anxiety: serotonin1a receptors as a common pharmacologic link. J Clin Psychiatry 58:20–26
Strowig AB (2000) Relapse determinants reported by men treated for alcohol addiction: the prominence of depressed mood. J Subst Abuse Treat 19:469–474
Tollefson GD, Montagu-Clouse J, Tollefson SF (1992) Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). J Clin Psychopharmacol 12:19–25
Ulrichsen J (1991) Alterations in serotonin receptor subtypes in ethanol-dependent rats. Alcohol Alcohol 26:567–573
Wallis CJ, Rezazadeh SM, Lal H (1993) Role of serotonin in ethanol abuse. Drug Dev Res 30:178–188
Wiesbeck GA,Weijers HG, Chick J, Naranjo A, Boening J (1999) Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled double-blind international multi-center trial. Ritanserin in Alcoholism Work Group. Alcohol Clin Exp Res 23:230–235
Wiesbeck GA, Weijers HD, Chick J, Boening J (2000) The effects of ritanserin on mood, sleep, vigilance, clinical impression, and social functioning in alcohol-dependent individuals. Ritanserin in Alcoholism Work Group. Alcohol Alcohol 35:384–389
Yocca FD (1990) Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postynaptic 5-HT1A receptors. J Clin Psychopharmacol 10:6S–12S
Acknowledgements
We wish to thank Matthew Crist, Dhritiman Mukherjee, Rebecca Overstreet, Leo Orlov, and Qi Yu for technical assistance. We thank the Case Western University web site for information about the affinity of the various serotonergic drugs (www.pdsp.cwru.edu/pdsp/asp). This work was supported by NIAAA grants AA 00243, AA 11605, and AA 00214.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Overstreet, D.H., Knapp, D.J., Moy, S.S. et al. A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats. Psychopharmacology 167, 344–352 (2003). https://doi.org/10.1007/s00213-003-1425-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-003-1425-y